Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 8

Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis

Total article views   HTML views PDF downloads Totals
25,495 Dovepress* 14,240+ 2,492 16,732
PubMed Central* 11,255 1,055 12,310
Totals 25,495 3,547 29,042
*Since 17 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
11 0 0 0 4 7

View citations on PubMed Central and Google Scholar